Summit Therapeutics Inc (NASDAQ:SMMT)

2.06
Delayed Data
As of Jan 21
 -0.17 / -7.62%
Today’s Change
2.06
Today|||52-Week Range
12.30
-23.42%
Year-to-Date
No recent news for Summit Therapeutics Inc.

Today’s Trading

Previous close2.23
Today’s open2.19
Day’s range2.06 - 2.19
Volume4,252
Average volume (3 months)184,338
Market cap$233.5M
Data as of 4:00pm ET, 01/21/2022

Growth & Valuation

Earnings growth (last year)-305.78%
Earnings growth (this year)+164.36%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+5.99%
P/E ratioNM
Price/Sales379.96
Price/Book2.48

Competitors

 Today’s
change
Today’s
% change
VRCAVerrica Pharmaceutic...-0.14-1.77%
MISTMilestone Pharmaceut...-0.35-4.90%
OVIDOvid Therapeutics In...-0.04-1.27%
HROWHarrow Health Inc-0.36-4.32%
Data as of 4:00pm ET, 01/21/2022

Financials

Next reporting dateMarch 16, 2022
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$860.0K
Annual profit (last year)-$52.7M
Net profit margin-6,127.56%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts